Meet Kimber Lockhart, the 33-year-old tech chief at One Medical who stands to make as much as $11.2 million as the company goes public

Lydia Ramsey,Yeji Jesse Lee

Jan 31, 2020, 22:30 IST

Meet Kimber Lockhart, the 33-year-old tech chief at One Medical who stands to make as much as $11.2 million as the company goes public

Courtesy of Kimber Lockhart

Kimber Lockhart

Kimber Lockhart, 33, is the chief technology officer at One Medical, a primary-care startup that went public on Friday.
Formerly the director of engineering at Box, Lockhart was responsible for a major redesign of Box's user interface before she joined One Medical in 2014 as the vice president of engineering. She stepped into her current role as CTO in 2015 at the age of 28.
Lockhart was selected as one of the honorees on Business Insider's list of the 30 leaders under 40 who are working to transform US healthcare.
When tackling something as complex as the US health industry, Lockhart told Business Insider that a piece of advice she often offers people looking to disrupt the healthcare field is to try "starting with a slightly smaller scope" instead of trying to reinvent the wheel.
Click here for more BI Prime stories.

At 33, Kimber Lockhart is in charge of overseeing technology at one of 2020's buzziest healthcare companies.

Lockhart is the chief technology officer and sits on the board of One Medical, a primary-care startup on Friday that went public after raising $245 million in its initial public offering.

Her stake in the firm could be worth $11.2 million based on the $18 share price at which One Medical started trading on Friday.

Last year, Business Insider selected Lockhart as one of the honorees on our list of the 30 leaders under 40 who are working to transform US healthcare. Here's a look at how Lockhart came to be the top tech leader at One Medical.

How Lockhart became chief technology officer at One Medical at 28

Lockhart graduated from Stanford with a bachelor's degree in computer science. At the age of 23, she sold Increo Solutions, a technology company that she had cofounded in 2007.

She sold Increo to Box, and joined the cloud storage startup company. There, Lockhart rose quickly through the ranks, starting as a software engineer and eventually becoming senior director of web application engineering in four years.

In 2014, Lockhart joined the healthcare sector when she started at One Medical as the vice president of engineering.

Within a year, she was promoted to chief technology officer, a role she continues in today. Lockhart's base salary in 2019 was $360,000, according to One Medical's IPO filing, which also shows that she owns 620,390 shares in the company.

Lockhart's advice about tackling the healthcare system

In an interview with Business Insider about disrupting the healthcare sector, Lockhart said that she often sees people wanting to completely redesign either one part or the entirety of the system. But the US healthcare system is complicated and overhauling things that have been in place for decades may be too tall of an order, she said.

"You have to understand all the stakeholders: the ecosystem of the buyer, the decision-maker, and the constraints that cause one person to choose one system over another," Lockhart said at the time.

Rather than trying to reinvent the wheel, then, it's about trying to make the wheel a little more efficient. One Medical uses a mobile app, which Lockhart oversees, that lets patients book appointments, renew prescriptions, message providers, and opt for "face-to-face virtual video visits."

That's part of her work on tools designed to improve the patient experience, from the time someone reaches out about a health symptom to the time they check out of the doctor's office, Business Insider previously reported.

"Wouldn't it be great if everyone had a guide to be able to say, 'Hey, is this the kind of thing I can video-chat with someone about? Or should I come in and see someone? Or do I need a specialist'," she said.

One Medical's app and much of its software can serve as that guide, she told Business Insider's Erin Brodwin.

"We do as much as we can to shoulder the burden with patients," Lockhart said.